NI
Numeric Investors Portfolio holdings
AUM
$13.7B
1-Year Return
28.85%
This Quarter Return
+1.22%
1 Year Return
+28.85%
3 Year Return
+71.66%
5 Year Return
–
10 Year Return
–
AUM
$6.75B
AUM Growth
+$66.9M
(+1%)
Cap. Flow
+$89.4M
Cap. Flow
% of AUM
1.32%
Top 10 Holdings %
Top 10 Hldgs %
20.26%
Holding
1,044
New
291
Increased
241
Reduced
243
Closed
249
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$64.4M |
| 2 |
Gen Digital
GEN
|
$52.3M |
| 3 |
Bunge Global
BG
|
$52.2M |
| 4 |
Microsoft
MSFT
|
$47.8M |
| 5 |
Gilead Sciences
GILD
|
$47.7M |
Top Sells
| 1 |
AbbVie
ABBV
|
$100M |
| 2 |
Wells Fargo
WFC
|
$69.8M |
| 3 |
CELG
Celgene Corp
CELG
|
$59.7M |
| 4 |
United Therapeutics
UTHR
|
$54.9M |
| 5 |
Everest Group
EG
|
$35.3M |
Sector Composition
| 1 | Financials | 18.11% |
| 2 | Technology | 17.96% |
| 3 | Healthcare | 11.98% |
| 4 | Energy | 9.63% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFC
301
Ellington Financial
EFC
$1.38B
| $2.57M | 0.04% |
115,701
-1,600
| -1% | -$35.6K |
|
302
ON Semiconductor
ON
$20.1B
| $2.55M | 0.04% |
284,745
-230,455
| -45% | -$2.06M |
|
|
PTLA
303
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.54M | 0.04% |
+100,511
| New | +$2.54M |
|
304
Great Southern Bancorp
GSBC
$719M
| $2.5M | 0.04% |
82,496
+32,956
| +67% | +$1,000K |
|
305
Flushing Financial
FFIC
$457M
| $2.46M | 0.04% |
134,576
+11,900
| +10% | +$217K |
|
|
ECYT
306
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $2.45M | 0.04% |
403,350
+345,438
| +596% | +$2.1M |
|
307
Eastman Chemical
EMN
$7.93B
| $2.45M | 0.04% |
+30,300
| New | +$2.45M |
|
308
Veracyte
VCYT
$2.55B
| $2.42M | 0.04% |
248,401
+177,135
| +249% | +$1.73M |
|
|
OLP
309
One Liberty Properties
OLP
$511M
| $2.31M | 0.03% |
114,387
+63,867
| +126% | +$1.29M |
|
310
Fifth Third Bancorp
FITB
$30.2B
| $2.31M | 0.03% |
115,400
+96,600
| +514% | +$1.93M |
|
|
CTP
311
DELISTED
CTPARTNERS EXECUTIVE SEARCH INC (DE)
CTP
| $2.31M | 0.03% |
+147,930
| New | +$2.31M |
|
|
ESRX
312
DELISTED
Express Scripts Holding Company
ESRX
| $2.28M | 0.03% |
+32,300
| New | +$2.28M |
|
313
Health Care Select Sector SPDR Fund
XLV
$34B
| $2.21M | 0.03% |
34,600
-700
| -2% | -$44.7K |
|
314
Marcus Corp
MCS
$483M
| $2.2M | 0.03% |
138,893
+100
| +0.1% | +$1.58K |
|
|
PMC
315
DELISTED
PharMerica Corporation
PMC
| $2.18M | 0.03% |
89,328
-243,690
| -73% | -$5.95M |
|
|
CLVS
316
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.17M | 0.03% |
47,800
-97,800
| -67% | -$4.44M |
|
|
DST
317
DELISTED
DST Systems Inc.
DST
| $2.15M | 0.03% |
51,200
-40,800
| -44% | -$1.71M |
|
|
EBIX
318
DELISTED
Ebix Inc
EBIX
| $2.14M | 0.03% |
150,545
-79,800
| -35% | -$1.13M |
|
319
VSE Corp
VSEC
$3.44B
| $2.11M | 0.03% |
86,180
-7,400
| -8% | -$181K |
|
320
1st Source
SRCE
$1.57B
| $2.11M | 0.03% |
81,488
-10,340
| -11% | -$268K |
|
|
PIR
321
DELISTED
Pier 1 Imports, Inc.
PIR
| $2.08M | 0.03% |
8,740
+1,670
| +24% | +$397K |
|
322
Steelcase
SCS
$1.97B
| $2.07M | 0.03% |
128,100
-132,600
| -51% | -$2.15M |
|
323
Silicon Motion
SIMO
$2.8B
| $2M | 0.03% |
+74,200
| New | +$2M |
|
|
TCO
324
DELISTED
Taubman Centers Inc.
TCO
| $1.99M | 0.03% |
27,300
-143,448
| -84% | -$10.5M |
|
|
RKT
325
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $1.99M | 0.03% |
41,740
-635,064
| -94% | -$30.2M |
|